Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab and Interleukin-12 in Head and Neck Squamous Cell Carcinoma
NCT01468896Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Oct 2011
- Primary completion
- Sep 2015
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant interleukin-12 in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Started Oct 2011; status: active, not recruiting.
02
Drugs
recombinant interleukin-12
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01468896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468896.